China's XtalPi Holdings, an AI and robotics-driven drug and materials discovery company, has debuted Kodexia™, the...
Merck, known as MSD outside of the United States and Canada, and China-based startup SciBrunch Therapeutics have entered...
China-based startup Abogen Biosciences, a clinical-stage biotechnology group pioneering RNA innovation, has entered...
A research team led by Prof. Hnin Yin Yin NYEIN from the Department of Chemical and Biological Engineering at The Hong K...
China-based Hengrui Pharma has entered into a license agreement with Novo Nordisk for HRS-1596, a phase I-ready glucagon...
Japan’s Chugai Pharmaceutical and InxMed (Hong Kong) have entered into a worldwide license agreement regarding SPY...
The Faculty of Computer and Mathematical Sciences (FCMS) of The Hong Kong Polytechnic University (PolyU) and the Institu...
InnoCare Pharma, a China-based biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, ha...
On March 13, 2026, China’s National Medical Products Administration (NMPA) granted Class III registration to NEO, ...
China is emerging as one of the world's most dynamic markets for neuroscience and mental health technologies. Driven by ...
China-based Sanyou Biopharmaceuticals and NovoCodex Biopharmaceuticals have jointly announced that the two companies hav...
HKSH Medical Group (HKSH) and United Imaging Healthcare (United Imaging) have announced the arrival of Hong Kong's first...
As Asia-Pacific’s manufacturing landscape becomes more sophisticated, purification and separation technolo...
Boomray Pharmaceuticals, a China-based clinical-stage biotechnology company pioneering innovative radioligand therapies ...
Akeso has received clearance from the Center for Drug Evaluation under China’s National Medical Products Administr...
IASO Biotechnology has received US Food and Drug Administration clearance for the Investigational New Drug application o...
WuXi XDC Cayman Inc., a leading global CRDMO (Contract Research, Development, and Manufacturing Organization) specialisi...
GSK plc has entered an agreement to acquire a potential best-in-class trispecific T cell-engager (TCE) from Chimagen Bio...
Sichuan Kelun-Biotech Biopharmaceutical has reported published Phase III results for trastuzumab botidotin in patients w...
Demand for advanced purification solutions is growing as industries look to improve performance while using less water a...
Novo Holdings, a leading global healthcare and life sciences investor, has announced a strategic minority investment in ...
China Medical System Holdings has announced that initial prescriptions for Silevimig Injection have been issued at multi...
Accro Bioscience and Fosun Pharma are preparing to advance AC-201 into a Phase II/III clinical trial in China for non-se...
Ascletis Pharma has initiated a US Phase I clinical study of ASC36 oral tablets, an investigational amylin receptor pept...
Kelun-Biotech has reported positive interim Phase II results for SKB378/WIN378, an investigational ultra-long-acting mon...
